Novartis scores FDA nod for game-changing SMA treatment
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
A key highlight will be Brenntag’s qualified amino acids portfolio
The partnership combines Croda’s deep expertise in smart science and global market reach with Amino’s advanced capabilities in precision manufacturing of amino acids
SOMA Color Mind is designed to simplify and accelerate color setup directly on the printing press
This collaboration turns kitting into a strategic advantage for sponsors and sites
The successful refinancing and enhancement of the syndicated credit facilities provides access to an additional CHF 40 million
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
Poviztra is a second brand of Wegovy
Subscribe To Our Newsletter & Stay Updated